Cargando…
The Evolving Treatment Options for Diabetic Macular Edema
Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR. This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the...
Autores principales: | Jain, Atul, Varshney, Neeta, Smith, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782842/ https://www.ncbi.nlm.nih.gov/pubmed/24106640 http://dx.doi.org/10.1155/2013/689276 |
Ejemplares similares
-
Diabetic Macular Edema: Therapeutic Options
por: Kulkarni, Amol D., et al.
Publicado: (2012) -
Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
por: Figueira, João, et al.
Publicado: (2021) -
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19
por: Iovino, Claudio, et al.
Publicado: (2021) -
Primary treatment of diabetic macular edema
por: Ranchod, Tushar M, et al.
Publicado: (2009) -
Corticosteroid Treatment in Diabetic Macular Edema
por: Nurözler Tabakcı, Burcu, et al.
Publicado: (2017)